NCT00102765已完成4 期
A Multicenter, Randomized, Double-Blind, Parallel Group, 52-Week Comparison of Asthma Control and Measures of Airway Inflammation in Subjects of African Descent Receiving Fluticasone Propionate/Salmeterol 100/50mcg DISKUS® BID or Fluticasone Propionate 100mcg DISKUS® BID Alone
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 479
- 试验地点
- 76
- 主要终点
- Asthma exacerbation rate per patient per year
研究概览
简要总结
This study will last up to 62 weeks. You will visit the clinic up to 17 times. Certain clinic visits will include physical examination, medical history review and lung function tests. The purpose of this study is to see if one asthma drug (fluticasone propionate/salmeterol) is better in reducing the number of asthma exacerbations compared with another drug (fluticasone propionate alone)
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 12 Years 至 65 Years(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Asthma exacerbation rate per patient per year
次要结局
- Morning peak flow measurement, percent of asthma symptom-free days, percent of albuterol-free days
研究者
研究点 (76)
Loading locations...
相似试验
已完成
4 期
Study Of Allergic Rhinitis In Patients Who Also Have AsthmaAsthmaNCT00296491GlaxoSmithKline725
已完成
4 期
Study Of Patients With Allergic Rhinitis And AsthmaAsthmaNCT00296530GlaxoSmithKline600
已完成
4 期
Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.Pulmonary Disease, Chronic ObstructiveNCT00355342GlaxoSmithKline186
已完成
2 期
Transdermal Continuous Oxygen Therapy for Diabetic Foot UlcersDiabetic Foot UlcersNCT01291160Neogenix, LLC dba Ogenix130
已完成
3 期
Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese PatientsChronic Obstructive Pulmonary DiseaseNCT01119937Novartis Pharmaceuticals211
